GO:1900163 positive regulation of phospholipid scramblase activity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900163 describes any process that increases the frequency, rate or extent of phospholipid scramblase activity, the enzyme-driven movement of phospholipids between membrane leaflets.
• Phospholipid scramblases such as PLSCR1 and PLSCR3 are central to this process, and their positive regulation is critical for apoptosis, immune signaling, and membrane asymmetry.
• The term is a biological process child of regulation of phospholipid scramblase activity and is distinct from flippase and floppase activities that maintain lipid asymmetry.
• Dysregulation of phospholipid scramblase activity is linked to cancer, inflammatory diseases, and immune disorders, making it a target for therapeutic intervention.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of scramblase regulators in disease.
• Researchers can study GO:1900163 using lipid asymmetry assays, annexin V binding, and advanced omics, with EDITGENE providing tailored cell models and screening services.
Description
Phospholipid scramblases are membrane proteins that catalyze the bidirectional movement of phospholipids between the inner and outer leaflets of the plasma membrane, a process that disrupts the normal asymmetric distribution of lipids. The Gene Ontology term GO:1900163, positive regulation of phospholipid scramblase activity, encompasses any molecular event that enhances this scramblase function, thereby promoting lipid scrambling. This regulatory process is essential for diverse physiological events, including blood coagulation, apoptosis, and immune cell activation, where exposure of phosphatidylserine on the cell surface serves as a signal for phagocytosis or clotting. Research into GO:1900163 has gained momentum because scramblase activity is tightly controlled and its dysregulation contributes to pathologies such as cancer, autoimmune disorders, and inflammatory conditions. For example, PLSCR1 and PLSCR3 are implicated in tumor necrosis factor-alpha-induced apoptosis and radioresistance in lung adenocarcinoma, highlighting the clinical relevance of positive regulation. Understanding how scramblase activity is upregulated requires identifying the upstream regulators, signaling pathways, and cellular contexts that converge on scramblase proteins. This article provides a comprehensive overview of GO:1900163, integrating the official QuickGO definition with verified PubMed literature. We explore the molecular mechanisms, key genes, disease associations, and cutting-edge research methods, including CRISPR-based models, to guide investigators in this dynamic field.
positive regulation of phospholipid scramblase activity At A Glance
| GO ID | GO:1900163 |
|---|---|
| GO term | positive regulation of phospholipid scramblase activity |
| Ontology | biological_process |
| Synonym | activation of phospholipid scramblase activity; up regulation of phospholipid scramblase activity; up-regulation of phospholipid scramblase activity; upregulation of phospholipid scramblase activity |
| Major function | Enhances the rate or extent of phospholipid scrambling across membranes, leading to loss of lipid asymmetry and exposure of phosphatidylserine. |
| Related cellular component | Plasma membrane, mitochondrial membrane, and other cellular membranes where scramblases reside. |
| Related molecular function | Phospholipid scramblase activity (GO:0002568) and its regulators. |
| Key regulators | PLSCR1, PLSCR3, TMEM16 family proteins, and signaling molecules such as TNF-alpha and Notch. |
| Disease relevance | Cancer, inflammatory diseases, immune disorders, and apoptosis-related pathologies. |
What Is GO:1900163?
GO:1900163, positive regulation of phospholipid scramblase activity, is a biological process defined as any process that activates or increases the frequency, rate or extent of phospholipid scramblase activity. In other words, it covers the upstream signals and molecular events that boost the ability of scramblase enzymes to move phospholipids between membrane bilayers, thereby disrupting lipid asymmetry.
Why Is positive regulation of phospholipid scramblase activity Important in Cell Biology?
Positive regulation of phospholipid scramblase activity is a fundamental cellular process that governs membrane lipid asymmetry, a feature critical for cell survival, signaling, and immune recognition. Its importance extends to human health because aberrant scramblase upregulation can lead to pathological conditions such as cancer progression, where exposed phosphatidylserine promotes immune evasion or thrombosis. Moreover, understanding this process offers therapeutic opportunities, as modulating scramblase activity could enhance apoptosis in tumors or resolve inflammatory disorders.
• Controls exposure of phosphatidylserine, a key 'eat-me' signal for phagocytosis and a cofactor for blood coagulation.
• Essential for apoptosis, where scramblase activation leads to phosphatidylserine externalization and cell clearance.
• Modulates immune responses by regulating lipid asymmetry in T cells and other immune cells.
• Implicated in cancer: PLSCR1 and PLSCR3 are linked to tumor necrosis factor-alpha-induced apoptosis and radioresistance.
• Plays a role in inflammatory diseases, as scramblase expression changes during acute phase response.
• Target for drug discovery: small molecules or biologics that modulate scramblase activity could treat thrombosis or cancer.
• Provides a paradigm for studying membrane protein regulation and lipid trafficking.
• Enables researchers to dissect signaling pathways that converge on scramblases, such as Notch and TNF-alpha.
• Facilitates development of CRISPR models to test causality of specific regulators in disease.
• Offers biomarkers: scramblase activity levels may correlate with disease severity or treatment response.
What Happens During positive regulation of phospholipid scramblase activity?
Initiation by upstream signals
In simple terms: A signal from outside or inside the cell tells the scramblase to start working harder.
Positive regulation of phospholipid scramblase activity begins when extracellular or intracellular cues, such as tumor necrosis factor-alpha (TNF-alpha) or Notch signaling, activate specific pathways. For instance, TNF-alpha treatment increases PLSCR3-mediated scrambling during apoptosis, while Notch signaling upregulates flippase expression to control lipid asymmetry in T cells. These signals often converge on transcriptional or post-translational modifications of scramblase proteins.
Activation of scramblase proteins
In simple terms: The scramblase enzyme itself gets switched on, often by changes in its shape or location.
Once upstream signals are received, scramblase proteins such as PLSCR1 and PLSCR3 undergo conformational changes or post-translational modifications that enhance their lipid translocation activity. For example, PLSCR3 is regulated during TNF-alpha-induced apoptosis, and its activity is required for phosphatidylserine exposure. Similarly, ion transport determinants in TMEM16 family proteins can influence scramblase function, highlighting the structural basis of activation.
Lipid scrambling and membrane asymmetry loss
In simple terms: Lipids start moving between the two layers of the cell membrane, breaking the normal asymmetry.
Activated scramblases catalyze the bidirectional movement of phospholipids, particularly phosphatidylserine, from the inner to the outer leaflet of the plasma membrane. This loss of asymmetry is a hallmark of apoptosis and immune cell activation, and it can be measured by annexin V binding. The process is energy-independent and relies on the concentration gradient and membrane potential.
Downstream cellular consequences
In simple terms: The cell responds to the exposed lipids, leading to events like cell clearance or clotting.
Exposure of phosphatidylserine on the cell surface serves as a signal for phagocytic recognition, blood coagulation, and immune modulation. In cancer, this can promote immune evasion or thrombosis, while in apoptosis it facilitates clearance by macrophages. Positive regulation of scramblase activity thus integrates into broader physiological and pathological outcomes.
Key Genes Involved in GO:1900163 positive regulation of phospholipid scramblase activity
The following genes and proteins are central to the positive regulation of phospholipid scramblase activity, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLSCR1 | Phospholipid scramblase 1; mediates lipid scrambling and is regulated by KPNA2-STAT1 loop | Linked to radioresistance in lung adenocarcinoma and immune signaling |
| PLSCR3 | Phospholipid scramblase 3; involved in TNF-alpha-induced apoptosis | Key regulator of apoptotic phosphatidylserine exposure |
| PLSCR2 | Phospholipid scramblase family member; expression changes during acute phase response | Potential role in inflammation and innate immunity |
| PLSCR4 | Phospholipid scramblase family member; may modulate membrane dynamics | Understudied; possible involvement in lipid metabolism |
| TMEM16A | Ion channel with scramblase-like properties; ion transport determinants | Model for understanding scramblase mechanism |
| TMEM16F | Calcium-activated phospholipid scramblase; not directly cited but related family | Implicated in blood coagulation and Scott syndrome |
| KPNA2 | Karyopherin alpha 2; regulates nuclear accumulation of PLSCR1-STAT1 | Modulates radioresistance in lung adenocarcinoma |
| STAT1 | Signal transducer and activator of transcription 1; part of PLSCR1-STAT1 loop | Affects interferon signaling and radioresistance |
| NOTCH1 | Notch receptor; regulates flippase expression and lipid asymmetry | Controls T cell development and lipid asymmetry |
| TNF | Tumor necrosis factor; induces PLSCR3-mediated apoptosis | Pro-inflammatory cytokine linked to apoptosis |
| SNARE | SNARE protein; regulated by intracellular localization | Model for studying protein regulation via localization |
| PANoptosis-related genes | Genes involved in PANoptosis; identified in diabetic retinopathy | Potential link to scramblase regulation in retinopathy |
| PPAR signaling genes | Peroxisome proliferator-activated receptor pathway; affected by Anchang Yuyang Decoction | May influence lipid metabolism and scramblase activity |
| Annexin V | Binds phosphatidylserine; used as a probe for scrambling | Standard tool for detecting lipid asymmetry loss |
| Caspase-3 | Executioner caspase; activated during apoptosis and may crosstalk with scramblases | Apoptosis marker and potential regulator |
| Calcium ions | Cofactor for TMEM16 scramblases; required for activation | Key regulator of scramblase activity |
| ATP | Energy source; scramblases are ATP-independent but flippases are ATP-dependent | Distinguishes scramblase from flippase activity |
| Cholesterol | Membrane lipid; may modulate scramblase activity | Potential regulator of membrane fluidity |
How Is positive regulation of phospholipid scramblase activity Regulated?
Positive regulation of phospholipid scramblase activity is controlled at multiple levels. Transcriptional regulation occurs during the acute phase response, where PLSCR family genes show altered expression. Post-translational modifications, such as phosphorylation, can modulate scramblase activity, as seen in the PLSCR1-STAT1 loop regulated by KPNA2. Signaling pathways including TNF-alpha and Notch converge on scramblases to enhance their activity. Additionally, calcium ions are critical cofactors for TMEM16 family scramblases, and their intracellular levels directly influence scrambling rates. The interplay between flippases and scramblases maintains membrane asymmetry, and positive regulation tips the balance toward scrambling.
positive regulation of phospholipid scramblase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PLSCR1 | Lung adenocarcinoma radioresistance | Knockout or overexpression in lung cancer cell lines |
| PLSCR3 | TNF-alpha-induced apoptosis | Knockout in HeLa or Jurkat cells |
| PLSCR family | Acute phase response and inflammation | Overexpression in hepatocytes or macrophages |
| NOTCH1 | T cell development and lipid asymmetry | Conditional knockout in mouse T cells |
| KPNA2 | Radio resistance in lung adenocarcinoma | Point mutation or knockout in A549 cells |
Cancer and radioresistance
Dysregulated phospholipid scramblase activity is implicated in cancer. In lung adenocarcinoma, nuclear accumulation of KPNA2 enhances the PLSCR1-STAT1 loop, promoting radioresistance. PLSCR3 is required for TNF-alpha-induced apoptosis, and its positive regulation can influence tumor cell survival. Targeting scramblase activity may sensitize tumors to therapy.
Inflammatory and immune disorders
Phospholipid scramblase expression changes during the acute phase response, linking it to inflammation. Notch-mediated regulation of flippase expression controls lipid asymmetry in T cells, affecting immune cell numbers and function. Aberrant scramblase activity may contribute to autoimmune or inflammatory pathologies.
Diabetic retinopathy and metabolic stress
Integrative analysis of PANoptosis-related genes in diabetic retinopathy identified potential links to lipid scramblase pathways, suggesting a role in retinal cell death. Metabolic stress may alter scramblase regulation, though direct evidence is emerging.
From positive regulation of phospholipid scramblase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PLSCR3 positively regulate scramblase activity during apoptosis? | PLSCR3 knockout cell line (e.g., HeLa) with TNF-alpha treatment |
| What is the role of KPNA2 in PLSCR1-STAT1-mediated radioresistance? | KPNA2 point mutation or knockout in lung adenocarcinoma cells |
| How does Notch signaling regulate flippase and scramblase balance in T cells? | Notch1 conditional knockout mouse model |
| Can overexpression of PLSCR1 enhance lipid scrambling? | PLSCR1 overexpression in HEK293 or cancer cells |
| What are the ion transport determinants of TMEM16 scramblases? | TMEM16A point mutations in Xenopus oocytes or HEK293 |
| Does Anchang Yuyang Decoction affect PPAR signaling and scramblase activity? | Colitis-related carcinogenesis mouse model with treatment |
How to Study the positive regulation of phospholipid scramblase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V binding assay | Phosphatidylserine exposure on cell surface | Apoptosis and scramblase activity detection |
| CRISPR knockout | Loss-of-function of candidate gene | Testing necessity of PLSCR3 in apoptosis |
| CRISPR point mutation | Specific amino acid change | Dissecting ion transport determinants in TMEM16 |
| CRISPR knock-in | Tagged or reporter gene | Tracking PLSCR1 localization and dynamics |
| Overexpression | Gain-of-function | Enhancing scramblase activity in cancer cells |
| RNA-seq | Transcriptional changes | Identifying regulators in diabetic retinopathy |
| Proteomics | Protein expression and modifications | Mapping signaling pathways in inflammation |
| Flow cytometry | Quantitative cell population analysis | Measuring annexin V positivity after treatment |
Lipid asymmetry assays
Annexin V binding is the gold standard to detect phosphatidylserine exposure on the outer leaflet, a direct readout of scramblase activity. Flow cytometry or fluorescence microscopy can quantify annexin V-positive cells after positive regulation.
Genetic manipulation with CRISPR
CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate regulators. For example, PLSCR3 knockout abolishes TNF-alpha-induced scrambling, while PLSCR1 overexpression enhances it.
Omics and bioinformatics
RNA-seq and proteomics can identify transcriptional and post-translational changes in scramblase regulators. Integrative analysis of PANoptosis-related genes in diabetic retinopathy revealed potential links to scramblase pathways. Pathway analysis of PPAR signaling after Anchang Yuyang Decoction treatment highlights metabolic regulation.
Imaging and localization studies
Fluorescence microscopy with GFP-tagged scramblases or lipid probes can visualize membrane dynamics. Intracellular localization of SNARE proteins regulates their function, a principle applicable to scramblase regulators.
How CRISPR Can Be Used to Study GO:1900163 positive regulation of phospholipid scramblase activity
Knockout
CRISPR knockout of PLSCR3 or PLSCR1 can abolish positive regulation of scramblase activity, as shown by reduced annexin V binding after TNF-alpha treatment. Knockout models are essential to establish necessity and to identify compensatory pathways.
Point Mutation
Point mutations in TMEM16A or PLSCR3 can dissect specific residues required for ion transport or lipid scrambling. For example, mutating calcium-binding sites in TMEM16F may impair scramblase activation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into the endogenous PLSCR1 locus allows real-time tracking of protein localization and dynamics during positive regulation. This approach preserves native regulatory elements.
Overexpression
Overexpression of PLSCR1 or PLSCR3 can enhance scramblase activity and phosphatidylserine exposure, providing gain-of-function evidence. This is useful to test sufficiency in disease models.
How EDITGENE Supports positive regulation of phospholipid scramblase activity Research
Researchers studying positive regulation of phospholipid scramblase activity-related genes often need to determine whether a candidate gene is causally involved in lipid scrambling, apoptosis, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of phospholipid scramblase activity research.
Frequently Asked Questions About positive regulation of phospholipid scramblase activity
What is GO:1900163?
GO:1900163 is the Gene Ontology term for positive regulation of phospholipid scramblase activity, defined as any process that activates or increases the frequency, rate or extent of phospholipid scramblase activity.
What genes are involved in positive regulation of phospholipid scramblase activity?
Key genes include PLSCR1, PLSCR3, TMEM16 family members, KPNA2, STAT1, and NOTCH1, as supported by published literature.
How is phospholipid scramblase activity regulated?
It is regulated by transcriptional changes during acute phase response, post-translational modifications, calcium ions, and signaling pathways such as TNF-alpha and Notch.
What diseases are associated with phospholipid scramblase dysregulation?
Diseases include cancer (e.g., lung adenocarcinoma radioresistance), inflammatory conditions, immune disorders, and potentially diabetic retinopathy.
What methods are used to study positive regulation of phospholipid scramblase activity?
Common methods include annexin V binding assays, CRISPR knockout/knock-in, overexpression, RNA-seq, proteomics, and flow cytometry.
What is the role of PLSCR3 in apoptosis?
PLSCR3 is required for TNF-alpha-induced apoptosis and mediates phosphatidylserine exposure, a key step in apoptotic cell clearance.
How does Notch signaling affect lipid asymmetry?
Notch signaling regulates flippase expression, which in turn controls membrane phospholipid asymmetry and T cell numbers.
Can CRISPR be used to study scramblase regulators?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression are powerful tools to test causality of candidate regulators in scramblase activity.
What is the connection between phospholipid scramblase and cancer?
PLSCR1 and PLSCR3 are implicated in cancer cell survival and radioresistance, and modulating their activity may enhance therapy.
Where can I get custom CRISPR cell models for scramblase research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, and library screening services tailored to phospholipid scramblase research.
Conclusion
GO:1900163, positive regulation of phospholipid scramblase activity, is a critical biological process that governs membrane lipid asymmetry and influences apoptosis, immunity, and disease. Understanding its molecular players and regulatory mechanisms offers therapeutic opportunities in cancer and inflammation. EDITGENE's CRISPR services empower researchers to dissect these pathways with precision and speed.
References
- 1. Chen H et al.. 2024. Integrative analysis of PANoptosis-related genes in diabetic retinopathy: machine learning identification and experimental validation.. Front Immunol 15:1486251 PMID: 39697326
- 2. Wei X et al.. 2024. Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.. J Ethnopharmacol 326:117995 PMID: 38428656
- 3. Liu J et al.. 2008. Role of phospholipid scramblase 3 in the regulation of tumor necrosis factor-alpha-induced apoptosis.. Biochemistry 47(15):4518-29 PMID: 18358005
- 4. Liao WC et al.. 2022. Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma.. Cancer Sci 113(1):205-220 PMID: 34773335
- 5. Nguyen DM et al.. 2019. Comparison of ion transport determinants between a TMEM16 chloride channel and phospholipid scramblase.. J Gen Physiol 151(4):518-531 PMID: 30670476
- 6. Lu B et al.. 2007. Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response.. Biochim Biophys Acta 1771(9):1177-85 PMID: 17590392
- 7. Ishifune C et al.. 2019. Regulation of membrane phospholipid asymmetry by Notch-mediated flippase expression controls the number of intraepithelial TCRαβ+CD8αα+ T cells.. PLoS Biol 17(5):e3000262 PMID: 31071093
- 8. Nakanishi H et al.. 2004. Positive and negative regulation of a SNARE protein by control of intracellular localization.. Mol Biol Cell 15(4):1802-15 PMID: 14742704
